- TFOS global ambassadors and international chapter affiliate
Singapore
Louis Tong
Louis Tong graduated in 1993 with a medical degree from the National University of Singapore, registered as a medical practitioner in 1994, obtained a Doctor of Medicine from University of Nottingham, United Kingdom in 2003, and achieved accreditation as an Ophthalmologist by the Singapore Medical Council in November 2004. He completed training in ophthalmology at various centers in England (1996-2000), Singapore (2000-2004), and a 2-year cornea research fellowship at Baylor College of Medicine in Houston, Texas. He obtained a Ph.D. from National University of Singapore in 2009. Dr. Tong holds several appointments including: Associate Professor, Duke-NUS Medical School, Adjunct Associate Professor, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, and Principal Clinician-Scientist; Head of Research Training & Development; Head of Ocular Surface Research Group; and Co-Head of Ocular Inflammation & Immunology research group, Singapore Eye Research Institute. Dr. Tong is among the International experts who have participated in TFOS International Meibomian Gland Dysfunction Workshop and TFOS Dry Eye Workshop II. He is a council member of Asia Dry Eye Society, a TFOS Global Ambassador for Singapore, and member of the International Ocular Surface Society. Dr. Tong is a frequent invited speaker at industry events, and at advisory board meetings for Alcon-Novartis, Allergan, and Santen. He has completed clinical trials sponsored by Alcon-Novartis, Allergan and Santen in the field of dry eye, and is currently part of a large collaborative program in translational research with Santen pharmaceuticals. Dr. Tong is Senior Consultant Ophthalmologist at Singapore National Eye Center, where he runs a dedicated dry eye clinic and performs pre-clinical translational research and clinical trials. He sees difficult dry eye cases and serves as a bridge for research project discussion and execution for other clinicians. Dr. Tong has been awarded over 20 grants totaling more than $10 million for studies involving the use of novel technologies to enhance evaporative dry eye care and a study on human tear pathophysiology, and he was awarded National Medical Research Council Clinician-Scientist award for investigator once, and as Senior Investigator twice. He also has patents in development for amphipathic lipids for dry eye and biomarkers for prediction of flares in systemic lupus erythematosus. Dr. Tong has written over 200 peer-reviewed papers in scientific journals and authored more than 15 book chapters/monographs in ophthalmology. He is on the Editorial Board of four scientific journals: Current Eye Research, Acta Ophthalmologica, American Journal of Molecular and Cellular Biology, and Ophthalmology and Therapy.